Martin Reincke Selected Research

Cortodoxone (11 Deoxycortisol)

1/2020	Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension.
1/2019	Steroid Profiling as an Additional Tool to Confirm One-Sided Hormone Overproduction in Primary Aldosteronism: A Case Report.
1/2018	Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome.
7/2017	Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Reincke Research Topics

Disease

100	Hyperaldosteronism (Conn Syndrome) 11/2022 - 12/2003
73	Adenoma (Adenomas) 11/2022 - 12/2003
56	Neoplasms (Cancer) 01/2022 - 02/2002
48	Cushing Syndrome 07/2022 - 11/2006
44	Hyperplasia 05/2022 - 03/2007
35	Hypertension (High Blood Pressure) 11/2022 - 12/2003
23	Pituitary ACTH Hypersecretion 07/2022 - 08/2014
12	Adrenocortical Carcinoma 01/2022 - 04/2004
9	Pheochromocytoma 01/2022 - 02/2002
7	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 08/2014
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2005
7	Pituitary Neoplasms (Pituitary Adenoma) 03/2021 - 10/2003
6	Muscular Diseases (Myopathy) 01/2022 - 06/2017
6	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 12/2014
5	Essential Hypertension 01/2020 - 06/2013
4	Osteoporosis 01/2022 - 10/2011
4	Adrenal incidentaloma 01/2022 - 01/2007
4	Insulin Resistance 01/2022 - 06/2013
4	Paraganglioma (Paragangliomas) 01/2022 - 12/2019
4	Endocrine System Diseases (Endocrine Diseases) 01/2021 - 06/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2020 - 03/2011
4	Myocardial Infarction 01/2020 - 01/2007
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2019 - 02/2010
3	Obesity 01/2022 - 10/2011
3	Infections 01/2022 - 04/2004
3	Bone Resorption 01/2021 - 01/2020
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 05/2009
3	Body Weight (Weight, Body) 11/2020 - 05/2012
3	Hypokalemia 10/2019 - 01/2015
3	Carcinogenesis 10/2018 - 09/2005
3	Acromegaly 01/2018 - 05/2009
2	COVID-19 01/2022 - 12/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2011
2	Diabetes Mellitus 01/2022 - 03/2014
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2021 - 12/2018
2	Neoplasm Metastasis (Metastasis) 06/2021 - 10/2019
2	Sarcopenia 01/2021 - 01/2019
2	Stroke (Strokes) 01/2020 - 12/2015
2	Lymphatic Metastasis 10/2019 - 02/2007
2	Heart Failure 10/2019 - 01/2007
2	Cognitive Dysfunction 04/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

95	AldosteroneIBA 01/2022 - 12/2003
45	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2022 - 08/2011
23	SteroidsIBA 01/2022 - 05/2005
21	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 05/2005
17	GlucocorticoidsIBA 01/2022 - 05/2009
16	ReninIBA 01/2022 - 12/2003
13	Hormones (Hormone)IBA 11/2022 - 02/2002
11	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 03/2004
11	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 03/2007
10	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2022 - 01/2014
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2013
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2014
7	PotassiumIBA 12/2021 - 02/2007
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
6	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 01/2007
6	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2019 - 03/2014
6	Ubiquitin-Specific ProteasesIBA 10/2019 - 07/2015
6	EnzymesIBA 10/2018 - 04/2004
5	Pharmaceutical PreparationsIBA 11/2022 - 01/2012
5	CatecholaminesIBA 01/2022 - 12/2015
5	Insulin-Like Growth Factor I (IGF-1)IBA 05/2021 - 03/2011
5	SaltsIBA 06/2020 - 07/2012
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 08/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2004
4	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 12/2020 - 04/2018
4	Cortodoxone (11 Deoxycortisol)IBA 01/2020 - 07/2017
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 04/2015
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021 - 12/2014
3	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2018
3	CalciumIBA 01/2021 - 02/2002
3	Mitotane (Lysodren)FDA Link 01/2021 - 02/2007
3	GTP-Binding Proteins (G-Protein)IBA 12/2020 - 01/2014
3	AutoantibodiesIBA 06/2020 - 10/2019
3	SodiumIBA 01/2020 - 12/2010
3	CorticosteroneIBA 01/2020 - 07/2017
3	LipidsIBA 01/2020 - 01/2020
3	ErbB Receptors (EGF Receptor)IBA 10/2018 - 01/2015
3	Growth Hormone (Somatotropin)IBA 01/2018 - 08/2009
3	AndrogensIBA 01/2018 - 01/2012
3	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 12/2017 - 01/2016
3	liposomal doxorubicin (Doxil)FDA Link 10/2016 - 05/2012
2	OsilodrostatIBA 01/2022 - 01/2021
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 12/2019
2	Insulin (Novolin)FDA Link 01/2022 - 06/2013
2	Everolimus FDA Link 01/2022 - 11/2019
2	AlpelisibIBA 01/2022 - 11/2019
2	pasireotideIBA 01/2022 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2022 - 06/2021
2	AntibodiesIBA 12/2021 - 12/2017
2	Insulin-Like Growth Factor Binding Protein 3IBA 05/2021 - 03/2011
2	Circulating MicroRNAIBA 01/2021 - 01/2019
2	Type 1 Angiotensin ReceptorIBA 06/2020 - 10/2019
2	Phosphates (Orthophosphate)IBA 04/2020 - 09/2002
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 10/2018
2	ParaffinIBA 01/2020 - 12/2017

Therapy/Procedure

49	Adrenalectomy 11/2022 - 09/2006
32	Therapeutics 11/2022 - 12/2003
5	Radiotherapy 12/2021 - 02/2007
3	Aftercare (After-Treatment) 01/2018 - 01/2011